In this study, we demonstrated the capability of CNCs-TMX to inhibit the proliferation, migration, and invasion of breast cancer cells by down-regulating the expressions of RAS, RAF, MEK and MAPK. This evidence concerns the gene MAP2K7 and breast carcinoma.